MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Risk of developing the Parkinson’s disease against the background of diabetes mellitus type 2.

    F. Akhmedova, M. Tukhtamishev (Tashkent, Uzbekistan)

    Objective: To evaluate whether type 2 diabetes at baseline is a risk factor for Parkinson's disease. Background: Parkinson’s disease is a chronic disorder in which…
  • 2019 International Congress

    Central Insulin Resistance Index is Independent of Peripheral Insulin Resistance in Parkinson’s disease

    M. Tagliati, E. Hogg, T. Wu, K. Makwana, H. Maghzi, A. Garland, E. Tan, C. Riera (Los Angeles, CA, USA)

    Objective: To correlate brain insulin signalling with peripheral insulin resistance using neuronally derived blood exosomes in patients with Parkinson's Disease (PD) Background: Insulin signaling abnormalities may…
  • 2019 International Congress

    Gender-dependent improvement in the survival of Parkinson’s disease patients in Finland

    T. Kuusimäki, S. Kurki, J. Sipilä, H. Salminen-Mankonen, O. Carpén, V. Kaasinen (Turku, Finland)

    Objective: To longitudinally investigate the overall survival (OS) of a large cohort of Parkinson's disease (PD) patients. Background: While there is evidence of increasing incidence,…
  • 2019 International Congress

    Study of Epidemiological Risk Factors in a Male-Only North Indian Parkinson’s Cohort

    K. Shukla, N. Sawal (Chandigarh, India)

    Objective: To study epidemiological factors contributing to the incidence of Parkinson’s disease at a tertiary care hospital in North India. Background: Pathogenesis of Parkinson’s disease…
  • 2019 International Congress

    Dysautonomia as a predictor of cognitive outcome after deep brain stimulation in Parkinson’s disease

    V. Cabreira, P. Castro, J. Freitas, M. Rosas, E. Azevedo (Porto, Portugal)

    Objective: To evaluate cognitive effects of subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkinson’s disease (PD) and to investigate whether subclinical autonomic dysfunction may…
  • 2019 International Congress

    Functional and dysfunctional impulsivities changes after deep brain stimulation of the subthalamic nucleus

    R. Kardous, B. Giordana, L. Stefanini, H. Joly, A. Mulliez, C. Giordana, B. Bailet, M. Borg, J. Yelnik, JJ. Lemaire, M. Benoit, D. Fontaine (Nice, France)

    Objective: We investigated changes of impulsivity after deep brain stimulation (DBS) of the subthalamic nucleus (STN) in Parkinson’s disease (PD) patients, distinguishing functional from dysfunctional…
  • 2019 International Congress

    Effects of three different physical therapies in body composition of Parkinson’s disease

    AOF. Fagundes, EPM. Monteiro, MSD. Delabary, APZ. Zanardi, MZC. Casal, VFM. Martins, MW. Wolffenbuttel, ANH. Haas, FGM. Martinez, LPT. Tartaruga (Porto Alegre, Brazil)

    Objective: Compare the effects of three physical therapies: dance (figure 1), deep water running (figure 2) and Nordic Walk (figure 3) in body composition of…
  • 2019 International Congress

    Public awareness and education of Parkinson’s Disease among Nepalese Population

    R. Ojha, R. Karn (Kathmandu, Nepal)

    Objective: This study aimed to evaluate the knowledge of Parkinson’s Disease(PD) among general population and educate them with the clinical features of this disease for…
  • 2019 International Congress

    Cognitive Processes That Indirectly Effect Olfactory Dysfunction in Parkinson’s Disease

    B. Chase, A. Mertens, J. Santo, K. Markopoulou (Omaha, NE, USA)

    Objective: Investigate cognitive mechanisms contributing to olfactory dysfunction in Parkinson’s disease. Background: Accurate early diagnosis of Parkinson’s disease is hampered by its long prodromal period…
  • 2019 International Congress

    Levodopa/carbidopa Intestinal Gel in Treatment of Non-Motor Symptoms in Advanced Parkinson’s Disease

    W. Kamel, J. Al Hashel (Beni Suef, Egypt)

    Objective: To identify the advantages of LCIG in the treatment of NMS among APD patients and appraise the currently available literature to identify the gaps…
  • « Previous Page
  • 1
  • …
  • 192
  • 193
  • 194
  • 195
  • 196
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • #24475 (not found)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley